Status:

COMPLETED

Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma

Lead Sponsor:

University of Michigan Rogel Cancer Center

Conditions:

Esophageal Cancer

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

Surgery (esophagectomy or removal of the esophagus)has been the standard treatment for cancer of the esophagus. However, evidence suggests that preoperative chemotherapy and radiation therapy may add ...

Eligibility Criteria

Inclusion

  • Patient Eligibility:
  • Histologically confirmed squamous cell carcinoma, adenocarcinoma, or mixed adeno/squamous of the the esophagus or gastroesophageal junction.
  • Disease limited to the esophagus and regional lymph nodes. However, celiac node enlargement will be acceptable for tumors of the distal esophagus, because they will be included in the radiation field.
  • Disease must be able to be encompassed in a single radiation field.
  • No medical contraindication to surgery.
  • All treatment is to be administered at the University of Michigan Medical Center
  • Karnofsky Performance Status \> 60%
  • Ages 18-75
  • Adequate renal function (BUN \<1.5 x N; creatinine \<1,5 mg/dl, or measured creatinine clearance\>60 ml/min.).
  • Adequate bone marrow reserve (WBC\>3500/ul; Platelets\>100,000/ul.).
  • Adequate hepatic function (Bilirubin\<1.5x N; AST \<2 x upper limit of normal).
  • Prior malignancy is acceptable if the patient is considered to be cured. In most cases this will mean a 5 year disease-free period.
  • Ability to give informed consent.
  • Exclusion Criteria:
  • Patients with active infection, pregnancy, lactating females, serious inter-current medical conditions including congestive heart failure, cardiac arrhythmias, or symptomatic coronary artery diseases are ineligible.
  • No prior treatment allowed. No prior thoracic radiation.

Exclusion

    Key Trial Info

    Start Date :

    November 1 1997

    Trial Type :

    INTERVENTIONAL

    End Date :

    July 1 2008

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00230451

    Start Date

    November 1 1997

    End Date

    July 1 2008

    Last Update

    January 15 2010

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Michigan Cancer Center

    Ann Arbor, Michigan, United States, 48197